Published May 2017 | Version v1
Journal article Metadata-only

Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer

Creators

  • 1. Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla (United States)
  • 2. Department of Oncology and Radiotherapy, University Hospital, Hradec Kralove (Czech Republic)
  • 3. Clinic of Radiotherapy, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice (Poland)
  • 4. Department of Radiation Oncology, Tata Memorial Hospital, Mumbai (India)
  • 5. Department of Radiology, Division of Nuclear Medicine, University of California San Diego, La Jolla (United States)

Description

BackgroundTo test the hypothesis that atlas-based active bone marrow (ABM)-sparing intensity modulated radiation therapy (IMRT) yields similar dosimetric results compared to custom ABM-sparing IMRT for cervical cancer patients.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2017.02.017

Additional details

Identifiers

DOI
10.1016/j.radonc.2017.02.017;
PII
S0167814017300944;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
123
Journal Issue
2
Journal Page Range
p. 325-330
ISSN
0167-8140
CODEN
RAONDT

INIS

Country of Publication
Ireland
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
50081007
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
AUTOMATION; BONE MARROW; NEOPLASMS; PATIENTS; RADIOTHERAPY
Descriptors DEC
ANIMAL TISSUES; BODY; DISEASES; HEMATOPOIETIC SYSTEM; MEDICINE; NUCLEAR MEDICINE; ORGANS; RADIOLOGY; THERAPY

Optional Information

Copyright
Copyright (c) 2017 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.